AzTrials
AzTrials

ICU Acquired WeaknessNCT05396066

Respiratory and Quadriceps Muscle Fatigability After an ICU Acquired Weakness

An observational study of ICU Acquired Weakness, run by Groupe Hospitalier du Havre at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Muscle dysfunction can be lead to poor outcomes moreover ICU muscle weakness recovery are not correctly described. The investigators aimed to assess the ability for quadriceps or respiratory muscles to repeat an effort at a maximal loading. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
ICU Acquired Weakness
What is being tested?
Muscle evaluation
How many people
20 participants
Where
1 siteFrance
Study dates
15 Jun 2022to 1 Feb 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients weaned from mechanical ventilation and developping ICU muscle weakness diagnosed by a maximal inspiratory pressure and a MRC score

Who may be able to join

  • Mechanically ventilated at least at 24 Hours
  • Maximal inspiratory pressure < 30 centimeter of water
  • MRC score < 48/60

Who cannot join

  • Age < 18 years
  • Patients with neurological pathology or pre existing neuromuscular dysfunction
  • Patient unable to walk 50 meters before ICU admission
  • Patient with a thoracic or abdominal surgery
  • Inability to carry out maximal voluntary contraction

Trial locations and contacts

1 site in 1 country.

France1 site
  • Groupe Hospitalier du Havre

    Montivilliers, Groupe Hospitalier Du Havre, 76290

Other trials in France

About this study

Official title: Comparison Between Respiratory and Quadriceps Muscle Fatigability During a Maximal Loading for ICU Weakness Patients

Muscle dysfunction can be lead to poor outcomes moreover ICU muscle weakness recovery are not correctly described.

The investigators aimed to assess the ability for quadriceps or respiratory muscles to repeat an effort at a maximal loading.

Being tested
Muscle evaluation
Keywords
ICU acquired weakness, Muscle strength, fatigability, respiratory muscle, Quadriceps muscle

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Muscle evaluationDiagnostic test

    Repeated maximal voluntary contraction

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Respiratory muscle strength

    Respiratory muscle strength will be assessed by Maximal Inspiratory pressure in centimeter of water. The measure will carry out by an electronical manometer

    Measured: One day

  2. Change in quadriceps muscle strength

    Quadriceps muscle strength will be assessed by Maximal Voluntary contraction of the quadriceps in Newton. The measure will carry out by an electronical dynamometer

    Measured: One day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 May 2022
  2. Study start15 Jun 2022
  3. Primary completion31 Dec 2023
  4. Study completion1 Feb 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05396066
Sponsor's protocol ID
2021-A02816-35
Status last verified
Jul 2024
First submitted
10 Mar 2022
Last updated
11 Jul 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Machefert M, Prieur G, Aubry S, Combret Y, Medrinal C. Respiratory and limb muscles' ability to repeatedly generate maximal isometric strength in patients with intensive care unit-acquired weakness: an observational study. BMC Anesthesiol. 2025 Mar 20;25(1):134. doi: 10.1186/s12871-025-03008-y.

    PubMed 40114068

Questions about this trial

What is this clinical trial studying?

An observational study of ICU Acquired Weakness, run by Groupe Hospitalier du Havre at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Respiratory muscle strength (time frame: One day). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05396066, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jul 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in